466 related articles for article (PubMed ID: 15341089)
1. [Yeast as a model for studying the prion and amyloid occurrence].
Kryndushkin DS; Aleksandrov IM; Kushnirov VV; Ter-Avanesian MD
Ross Fiziol Zh Im I M Sechenova; 2004 May; 90(5):645-57. PubMed ID: 15341089
[TBL] [Abstract][Full Text] [Related]
2. [Neurodegenerative amyloidoses: the yeast model].
Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
[TBL] [Abstract][Full Text] [Related]
3. Impact of Amyloid Polymorphism on Prion-Chaperone Interactions in Yeast.
Killian AN; Miller SC; Hines JK
Viruses; 2019 Apr; 11(4):. PubMed ID: 30995727
[TBL] [Abstract][Full Text] [Related]
4. Prions.
Kryndushkin D; Edskes HK; Shewmaker FP; Wickner RB
Cold Spring Harb Protoc; 2017 Feb; 2017(2):. PubMed ID: 28148884
[TBL] [Abstract][Full Text] [Related]
5. Life cycle of yeast prions: propagation mediated by amyloid fibrils.
Inoue Y
Protein Pept Lett; 2009; 16(3):271-6. PubMed ID: 19275740
[TBL] [Abstract][Full Text] [Related]
6. Prions are affected by evolution at two levels.
Wickner RB; Kelly AC
Cell Mol Life Sci; 2016 Mar; 73(6):1131-44. PubMed ID: 26713322
[TBL] [Abstract][Full Text] [Related]
7. Human J-protein DnaJB6b Cures a Subset of Saccharomyces cerevisiae Prions and Selectively Blocks Assembly of Structurally Related Amyloids.
Reidy M; Sharma R; Roberts BL; Masison DC
J Biol Chem; 2016 Feb; 291(8):4035-47. PubMed ID: 26702057
[TBL] [Abstract][Full Text] [Related]
8. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
[TBL] [Abstract][Full Text] [Related]
9. The utility of prions.
Osherovich LZ; Weissman JS
Dev Cell; 2002 Feb; 2(2):143-51. PubMed ID: 11832240
[TBL] [Abstract][Full Text] [Related]
10. [Yeast prions as a model of neurodegenerative infectious amyloidoses in humans].
Inge-Vechtomov SG
Ontogenez; 2011; 42(5):337-45. PubMed ID: 22145302
[TBL] [Abstract][Full Text] [Related]
11. Amyloid formation of a yeast prion determinant.
Scheibel T
J Mol Neurosci; 2004; 23(1-2):13-22. PubMed ID: 15126688
[TBL] [Abstract][Full Text] [Related]
12. [New aspects of research upon the yeast Saccharomyces cerevisiae [PSI+] prion].
Ishikawa T
Postepy Biochem; 2007; 53(2):182-7. PubMed ID: 17969880
[TBL] [Abstract][Full Text] [Related]
13. Prions.
Shkundina IS; Ter-Avanesyan MD
Biochemistry (Mosc); 2007 Dec; 72(13):1519-36. PubMed ID: 18282140
[TBL] [Abstract][Full Text] [Related]
14. Prion diseases of yeast: amyloid structure and biology.
Wickner RB; Edskes HK; Kryndushkin D; McGlinchey R; Bateman D; Kelly A
Semin Cell Dev Biol; 2011 Jul; 22(5):469-75. PubMed ID: 21345375
[TBL] [Abstract][Full Text] [Related]
15. Structural Bases of Prion Variation in Yeast.
Kushnirov VV; Dergalev AA; Alieva MK; Alexandrov AI
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628548
[TBL] [Abstract][Full Text] [Related]
16. How Do Yeast Cells Contend with Prions?
Wickner RB; Edskes HK; Son M; Wu S; Niznikiewicz M
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635197
[TBL] [Abstract][Full Text] [Related]
17. Mutations Outside the Ure2 Amyloid-Forming Region Disrupt [URE3] Prion Propagation and Alter Interactions with Protein Quality Control Factors.
Kumar S; Dine EA; Paddock E; Steinberg DN; Greene LE; Masison DC
Mol Cell Biol; 2020 Oct; 40(21):. PubMed ID: 32868289
[TBL] [Abstract][Full Text] [Related]
18. Prions: infectious proteins with genetic properties.
Ter-Avanesyan MD; Kushnirov VV
Biochemistry (Mosc); 1999 Dec; 64(12):1382-90. PubMed ID: 10648962
[TBL] [Abstract][Full Text] [Related]
19. Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein.
Kushnirov VV; Vishnevskaya AB; Alexandrov IM; Ter-Avanesyan MD
Prion; 2007; 1(3):179-84. PubMed ID: 19164899
[TBL] [Abstract][Full Text] [Related]
20. Ageing in yeast does not enhance prion generation.
Shewmaker F; Wickner RB
Yeast; 2006 Dec; 23(16):1123-8. PubMed ID: 17133618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
